Delivery Order SPE2DB20D3303-SPE2DB24FA3PG

Award Date 9/26/24
Potential Completion Date 9/27/24
Potential Value $6.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,972.75 firm fixed-price delivery order is for the supply of Lidocaine 5% Patches. The contract has an ultimate completion date of January 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lidocaine 5% Patches. The fixed-price delivery order, valued at $4,651.69, has a completion date of January 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies for military healthcare...
The federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,923.44 firm-fixed-price delivery order is for the supply of Lidocaine 5% Patches, with an ultimate completion date of October 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,125.50 firm fixed-price delivery order is for the provision of Lidocaine 5% Patches and has a completion date of November 15, 2024. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,583.38 firm-fixed-price delivery order is for the provision of 4566088364 - Lidocaine 5% Patches. The contract has an ultimate completion date of October 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lidocaine 5% patches. The $1,233.60 firm fixed-price delivery order has a completion date of December 21, 2022 and is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,930.52 firm fixed-price delivery order is for the supply of Lidocaine 5% Patches, with a completion date of July 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,774.11 firm fixed-price delivery order is for the supply of 4565641551 - Lidocaine 5% Patch 30S medical products. The contract has a completion date of September 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award is a delivery order valued at $3,234.04 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lidocaine 5% Patches and has a period of performance through October 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Lidocaine 5% Patches. The award, valued at $4,798.95, is a Delivery Order contract with a Firm Fixed Price pricing type. The contract has an ultimate completion date of September 20, 2024 and was awarded on September 19, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA3PG
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Lidocaine 5% Patches. The $6,643.30 firm-fixed-price contract is a delivery order awarded without a set-aside designation, with a completion date of September 27, 2024.

AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. This specific award is part of that broader IDC, enabling the government to efficiently procure critical pharmaceutical products from a trusted vendor.

Generated 12/26/24, 9:25 AM